{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T03:01:53Z","timestamp":1721185313148},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["zefq-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.zefq.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T08:00:47Z","timestamp":1506585647000},"page":"1-7","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bedarfsanalyse zur Verbesserung der Anwendbarkeit und methodischen Qualit\u00e4t einer S3-Leitlinie"],"prefix":"10.1016","volume":"131-132","author":[{"given":"Marion","family":"Burckhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Nink-Grebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"S\u00e4nger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.zefq.2017.09.002_bib0095","unstructured":"Deutsche Gesellschaft f\u00fcr Wundheilung und Wundbehandlung e.V. (Hrsg.). S3-Leitlinie: Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronische ven\u00f6se Insuffizienz. Stand: 12.06.2012 Version 1. 2012 20.07.2012; [1\u2013287]. Internet: http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/091-001l_S3_Lokaltherapie_chronischer_Wunden_2012-06.pdf. [Stand 06.02.2017]."},{"key":"10.1016\/j.zefq.2017.09.002_bib0100","unstructured":"Burckhardt M., et al. Leitlinienreport. S3-Leitlinie Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronische ven\u00f6se Insuffizienz. 2012 20.07.2012; Internet: http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/091-001.html [Stand 06.02.2017]."},{"issue":"27\u201328","key":"10.1016\/j.zefq.2017.09.002_bib0105","first-page":"1248","article-title":"Wundbehandlung: Wertvolles vermehren, \u00dcberfl\u00fcssiges reduzieren","volume":"111","author":"Burckhardt","year":"2014","journal-title":"Deutsches Arzteblatt"},{"key":"10.1016\/j.zefq.2017.09.002_bib0110","unstructured":"Institute of Medicine, Clinical Practice Guidelines We Can Trust, ed. R. Graham, et al. 2011, Washington DC: National Academy of Sciences."},{"key":"10.1016\/j.zefq.2017.09.002_bib0115","unstructured":"AWMF AWMF-Regelwerk \u201eLeitlinien\u201c. 1. Auflage 2012. 2012. Internet: http:\/\/www.awmf.org\/leitlinien\/awmf-regelwerk.html [Stand 28.06.2015]."},{"key":"10.1016\/j.zefq.2017.09.002_bib0120","unstructured":"AGREE Next Steps Consortium. The AGREE II Instrument [Electronic version]. 2009 03.09.2015; Internet: http:\/\/www.agreetrust.org [Stand 15.04.2016]."},{"issue":"7305","key":"10.1016\/j.zefq.2017.09.002_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.323.7305.155","article-title":"When should clinical guidelines be updated?","volume":"323","author":"Shekelle","year":"2001","journal-title":"The British Medical Journal"},{"key":"10.1016\/j.zefq.2017.09.002_bib0130","unstructured":"Leitlinienwatch. Das Transparenzportal f\u00fcr medizinische Behandlungsleitlinien: Bewertete Leitlinien: Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronisch ven\u00f6se Insuffizienz. 2017; Internet: https:\/\/www.leitlinienwatch.de\/bewertete-leitlinien\/ [Stand 15.01.2017]."},{"key":"10.1016\/j.zefq.2017.09.002_bib0135","unstructured":"Zentrum f\u00fcr Qualit\u00e4t in der Pflege. Pflegerische Leitlinien und Standards: Lokaltherapie chronischer Wunden bei Patienten mit den Risiken periphere arterielle Verschlusskrankheit, Diabetes mellitus, chronische ven\u00f6se Insuffizienz. 2015; Internet: https:\/\/lls.zqp.de\/data.php?lang=de&id=98&sort=a&name=Lokaltherapie-chronischer-Wunden-bei-Patienten-mit-den-Risiken-periphere-arterielle-Verschlusskrankheit,-Diabetes-mellitus,-chronische-ven%C3%B6se-Insuffizienz [Stand 15.01.2017]."},{"issue":"1","key":"10.1016\/j.zefq.2017.09.002_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-5-44","article-title":"A systematic review on the impact of leg ulceration on patients\u2019 quality of life","volume":"5","author":"Herber","year":"2007","journal-title":"Health and Quality of Life Outcomes"},{"issue":"10","key":"10.1016\/j.zefq.2017.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1016\/j.zefq.2017.09.002_bib0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.zefq.2017.09.002_bib0155","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften AWMF-Regel f\u00fcr das Leitlinienregister: Erkl\u00e4rung von Interessen und Umgang mit Interessenkonflikten bei Leitlinienvorhaben Version 2.3, Stand: 30.06.2016 \u2013 Betaversion f\u00fcr Praxistest. 2016."},{"issue":"5","key":"10.1016\/j.zefq.2017.09.002_bib0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jclinepi.2014.12.013","article-title":"Guideline uptake is influenced by six implementability domains for creating and communicating guidelines: a realist review","volume":"68","author":"Kastner","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1016\/j.zefq.2017.09.002_bib0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/XEB.0000000000000036","article-title":"Format guidelines to make them vivid, intuitive, and visual: use simple formatting rules to optimize usability and accessibility of clinical practice guidelines","volume":"13","author":"Versloot","year":"2015","journal-title":"International Journal of Evidence-based Healthcare"},{"issue":"8","key":"10.1016\/j.zefq.2017.09.002_bib0170","first-page":"CD010669","article-title":"Tools developed and disseminated by guideline producers to promote the uptake of their guidelines","author":"Flodgren","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.zefq.2017.09.002_bib0175","first-page":"7","article-title":"Hochwertige Versorgung von Krebspatienten unter deutschen Strukturvorgaben","volume":"15","author":"Bruns","year":"2015","journal-title":"GGW"},{"issue":"1","key":"10.1016\/j.zefq.2017.09.002_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajag.12083","article-title":"National consultation informing development of guidelines for a palliative approach for aged care in the community setting","volume":"34","author":"Holloway","year":"2015","journal-title":"Australasian Journal on Ageing"}],"container-title":["Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1865921717301897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1865921717301897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T03:25:46Z","timestamp":1535340346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1865921717301897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":18,"alternative-id":["S1865921717301897"],"URL":"https:\/\/doi.org\/10.1016\/j.zefq.2017.09.002","relation":{},"ISSN":["1865-9217"],"issn-type":[{"value":"1865-9217","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bedarfsanalyse zur Verbesserung der Anwendbarkeit und methodischen Qualit\u00e4t einer S3-Leitlinie","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zefq.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}